Startup Fundraising 101: All You Need To Know
By CJ Benjamin · Lead Brand Strategist, Brandroom Inc. · May 2026
Let me say this plainly: most founders who walk into a fundraising conversation are unprepared, not because they lack a great idea, but because nobody ever explained the mechanics to them clearly.
The vocabulary of venture capital was designed to be opaque. Term sheets, pre-money valuations, post-money SAFEs, liquidation preferences, pro rata rights, and fully diluted cap tables—each of these terms is a lever. And if you don’t know what it does, someone else will pull it for you.
This article exists to change that.
Whether you are raising your first check or preparing for your Series A, everything you need to understand about startup fundraising starts here.
PART ONE: THE STAGES OF FUNDING
Fundraising is not a single event. It is a sequence, each stage with its own investors, its own expectations, its own risk profile, and its own benchmark for what “ready” actually means.
Here is the full journey, with 2026 benchmarks.
PRE-SEED
What it is: The earliest stage of external capital. You have an idea, a prototype, or a very early product. Revenue is rare. Traction is minimal. You are asking investors to bet on you and a vision — almost nothing else.
Who invests: Founders, friends and family, angel investors, and early-stage micro-VCs. In some cases, accelerators like Y Combinator or Techstars write pre-seed checks as part of their programme.
Typical raise: Around $500,000.
Typical valuation: $5 million to $10 million post-money.
Typical dilution: 15% to 25%.
What investors want to see: A founder who understands the problem deeply, evidence that the problem is real, and a credible hypothesis for the solution.
The honest reality: Pre-seed investors are betting on you more than your product. Your conviction, your clarity, and your credibility in the problem space carry more weight here than any deck.
SEED
What it is: The first institutional round. You have a working product — sometimes with early revenue, sometimes without — and you are trying to find product-market fit.
Who invests: Angel investors, seed-focused VCs, and accelerators. In 2026, seed investors are increasingly sophisticated, they expect more than a concept.
Typical raise: Around $3 million.
Typical valuation: $10 million to $25 million post-money.
Typical dilution: Median sits at roughly 19% as of 2025.
What investors want to see: A working product with real users, early signal that people want what you’re building, and a founder who can execute.
The honest reality: The bar for seed funding has risen significantly since 2021. Pre-seed investors now frequently require early revenue. Seed investors want demonstrable product-market fit — or at least a compelling path to it. The gap between seed and Series A is where most startups die. Fewer than 15% of seed-funded startups in the US raise a Series A within three years.
SERIES A
What it is: The first major growth round. You have validated your product and found product-market fit. Now you need capital to scale — to hire, to formalize your go-to-market, and to prove you can grow efficiently.
Who invests: Early-stage venture capital firms. This is where institutional investors with formal processes, due diligence teams, and serious term sheets enter the picture.
Typical raise: Around $15 million.
Typical valuation: $40 million to $120 million post-money.
Typical dilution: Median approximately 17.9% as of Q1 2025 — down from 20.9% a year earlier, driven by rising valuations.
What investors want to see: The minimum ARR for a competitive Series A pitch in 2026 is $1.5 million, with top-performing companies showing $3 million or more. Investors want a repeatable, revenue-driven growth engine not just a product that works.
The honest reality: Series A marks the shift from proving that your idea works to proving that it can scale. If you can’t articulate a clear model for repeatable growth and the unit economics behind it, the round will be a hard close regardless of how good the product is.
What it is: A growth acceleration round. You have product-market fit and proven unit economics. Now you are expanding into new markets, geographies, or product lines.
SERIES B
Who invests: Growth-stage VCs (Insight Partners, Tiger Global, General Atlantic, Iconiq), corporate strategic investors.
Typical raise: Around $30 million.
Typical valuation: $100 million to $300 million post-money.
Typical dilution: Approximately 13% — the steepest single-stage dilution decline that year, driven by rising valuations.
SERIES C AND BEYOND
What investors want to see: $5 million to $15 million ARR. Proof that the engine works and that capital will accelerate it, not build it.
What it is: At this stage, you are no longer a startup in the traditional sense. You are building a company. Series C and beyond — Series D, E, F, and pre-IPO rounds are for significant expansion, international growth, strategic acquisitions, and preparation for a public offering.
Typical raise: Series C averages around $60 million. Series D averages around $100 million. Series E and beyond can reach $200 million or more.
Typical valuation: Series C: $250 million to $600 million. Series D: $500 million to $1.5 billion. Series E+: $1 billion to $5 billion and above.
What investors want to see: Consistent, compounding growth. Strong leadership. A business that behaves like a public-level organization with global reach and established revenue engines.
The honest reality: According to data from multiple Crunchbase and PitchBook analyses, only about 1% of startups that raise seed funding progress to Series C and beyond. The fundraising journey is a funnel — and it gets narrower, more demanding, and more scrutinized at every level
PART TWO: VALUATION—WHAT YOUR COMPANY IS ACTUALLY WORTH
Valuation is one of the most misunderstood concepts in early-stage fundraising. Most founders either undervalue their company out of inexperience or overvalue it out of optimism and both mistakes are expensive.
Here is how valuation actually works.
PRE-MONEY vs. POST-MONEY VALUATION
Pre-money valuation is what your company is worth before the investment comes in.
Post-money valuation is what it is worth after investment, which is simply pre-money valuation plus the investment amount.
Example:
— Your pre-money valuation is $9 million.
— An investor puts in $1 million.
— Your post-money valuation is $10 million.
— The investor now owns 10% of the company ($1M ÷ $10M).
This formula is the foundation of every fundraising negotiation. The higher your pre-money valuation, the less equity you give away for the same check size.
HOW VALUATIONS ARE DETERMINED AT EARLY STAGES
In the early stage, there is no revenue to anchor a valuation. So investors use a combination of factors:
→ The size and quality of the market opportunity
→ The founder’s background, track record, and credibility
→ The uniqueness and defensibility of the solution
→ Early traction — users, signups, letters of intent, revenue
→ Comparable recent deals in the same space (comparables)
→ The overall sentiment of the market toward that sector
In 2026, the median post-money seed valuation reached $24 million in Q4 2025 — up from $18 million a year earlier. AI and machine learning companies command significantly higher valuations than the median at every stage.
Valuation at early stages is, to a meaningful degree, a negotiation informed by evidence. Know your comparables. Know your metrics. Know what you are willing to give up and what you are not.
PART THREE: THE CAP TABLE
The capitalization table, or the cap table, is a single document that contains the complete picture of who owns what in your company. Every investor, every founder, every advisor, every employee with stock options, all of it lives in the cap table.
It is not a spreadsheet. It is a record of every commitment you have ever made to another person in exchange for their capital, their time, or their talent. Treat it accordingly.
WHAT THE CAP TABLE CONTAINS
A clean cap table lists:
→ Every shareholder — founders, investors, employees, advisors
→ The number of shares each person holds
→ The type of equity — common stock, preferred stock, options, warrants, convertible notes, SAFEs
→ The ownership percentage of each shareholder
→ The price paid per share in each round
→ The fully diluted share count — meaning all outstanding shares plus all shares that could be issued from unexercised options, unmatured SAFEs, and unconverted notes
That last point — fully diluted — is critical. Founders who calculate their ownership based only on issued shares are underestimating how much they have actually given away.
COMMON STOCK vs. PREFERRED STOCK
When you as a founder receive equity at incorporation, it is almost always common stock.
When investors put money into your company, they almost always receive preferred stock.
Preferred stock is not the same as common stock. It comes with a suite of rights that protect investors in the event of a sale or liquidation:
→ Liquidation preference: The right to get their money back first before common shareholders receive anything. A 1x liquidation preference means investors recover their investment in full before founders see a dollar. Some deals include 2x or 3x preferences — a serious risk to founder economics in a below-expectation exit.
→ Participation rights: Some preferred shares are “participating,” meaning investors collect their liquidation preference and then also share in the remaining proceeds alongside common shareholders. This double-dips. It is investor-friendly. It should be negotiated carefully.
→ Anti-dilution protection: If your company raises a future round at a lower valuation (a down round), anti-dilution provisions protect investors by adjusting their conversion rate upward. This protects the investor and dilutes the founder further.
Know what kind of preferred stock you are issuing before you sign anything.
PART FOUR: EQUITY AND DILUTION
Dilution is the single most important concept in startup fundraising that founders systematically underestimate.
Every time you raise a new round, you issue new shares. Those new shares expand the total share count. Your number of shares stays the same — but as a percentage of the total, it shrinks. That is dilution.
THE MATH OF DILUTION ACROSS ROUNDS
Here is what founder ownership typically looks like as a company progresses through funding, based on Carta’s founder ownership data:
→ At incorporation: ~100%
→ After seed round: ~56%
→ After Series A: ~36%
→ After Series B: ~23%
By Series C, median founder ownership falls below the employee option pool for the first time.
The steepest drops happen at the earliest stages, which is exactly when founders are least equipped to negotiate. The decisions you make at pre-seed and seed about valuation, instrument structure, and how much equity you give advisors and early team members compound forward through every subsequent round.
THE OPTION POOL
The employee stock option pool (ESOP) is a block of equity reserved for future employees, advisors, and consultants. It is a recruiting tool — it allows you to attract talent by offering ownership in what the company might become.
Standard option pool sizes:
→ Seed stage: 10% to 15% of fully diluted shares
→ Series A: Investors typically require a refresh to 15% to 20%
Here is the critical detail most founders miss:
Investors will typically require the option pool to be created or expanded before the round closes — in pre-money terms. This means the dilution from expanding the pool comes entirely from you, not from the incoming investor. A term sheet that says “$10 million pre-money with a 20% option pool” is not the same as a clean $10 million pre-money valuation. Model it.
Median equity grants for early hires in 2025: first hire at roughly 1.49% of fully diluted shares, fifth hire at roughly 0.34%, tenth hire at roughly 0.18%.
VESTING SCHEDULES
Equity is not handed to founders and employees all at once. It vests — it is earned over time, according to a schedule.
The standard vesting schedule is four years with a one-year cliff:
→ The cliff means no equity vests until after 12 months
→ After the cliff, the remaining equity vests monthly or quarterly over the remaining three years
→ If someone leaves before the cliff, they receive nothing
Vesting applies to founders too. If you have a co-founder and no vesting agreement, and they leave six months in, they walk away with whatever percentage you agreed to give them on day one. This has destroyed companies. Get a vesting agreement in place at incorporation.
PART FIVE: INSTRUMENTS — HOW MONEY ACTUALLY MOVES
Not all fundraising rounds involve selling priced equity directly. Two instruments dominate early-stage fundraising, and every founder needs to understand them.
THE SAFE (Simple Agreement for Future Equity)
A SAFE is not equity. It is not a loan. It is a contract that gives an investor the right to receive equity in a future priced round — typically at a discount to what new investors pay, and/or at a capped valuation.
SAFEs have become the dominant pre-seed instrument. In the first half of 2025, 96% of SAFEs issued included a valuation cap — up from 86% in 2024. They are popular because they are simple, fast to close, and require no company valuation at the time of signing.
Key SAFE terms:
→ Valuation cap: The maximum valuation at which the SAFE converts into equity. A $5 million cap on a SAFE means the investor converts as if the company were worth no more than $5 million — even if the next round is priced at $15 million. This rewards early investors for taking early risk.
→ Discount: Typically 10% to 20% off the next round price. Additional protection for the early investor.
The danger: SAFEs create what practitioners call phantom equity — ownership you have committed to giving away that does not appear on your cap table until a priced round triggers conversion. Founders who stack multiple SAFEs at different valuation caps without modeling the conversion outcomes are routinely caught off guard at their first priced round. Model every SAFE before you sign it.
CONVERTIBLE NOTES
Convertible notes function similarly to SAFEs but are debt instruments. They accrue interest (typically 2% to 8% annually) and have a maturity date by which they must either convert to equity or be repaid. They include the same valuation caps and discount mechanisms as SAFEs.
Convertible notes add complexity — a repayment obligation that SAFEs do not carry. In most early-stage situations today, a SAFE is preferable for both founders and investors. But in certain markets and jurisdictions, convertible notes remain standard.
PART SIX: WHAT INVESTORS ARE ACTUALLY LOOKING FOR
Understanding the mechanics is necessary. Understanding the mindset on the other side of the table is essential.
Venture capital investors are not philanthropists. They are fund managers with a specific mandate: return capital to their limited partners at a multiple that justifies the risk of investing in early-stage companies.
The math works like this: most early-stage investments will fail. A small number will return modest multiples. One or two will return 10x, 50x, or 100x — and those are the investments that make the fund.
This means investors are not looking for businesses that will probably do fine. They are looking for businesses that could become very large, very fast.
What this means for founders:
→ Market size matters more than most founders realize. Investors want to see a market large enough that even a small share represents a big company.
→ Traction is not just proof of product quality. It is proof that the market exists and that this team can capture it.
→ The team is evaluated as much as the product. In the early stages, especially, investors are betting on whether you have the judgment, resilience, and adaptability to navigate what is coming.
→ According to Techstars data, it typically takes 100 to 200 investor conversations to close a solid funding round. Fundraising is a volume game filtered through relationship quality. Start building relationships before you need money, not when you do.
→ The founders who close quickly are the ones who understood the next stage’s expectations before they started raising.
PART SEVEN: THE MISTAKES THAT KILL RAISES
Here are the most common and most avoidable mistakes founders make in fundraising.
→ Too much dilution too early. Giving away 40% at pre-seed leaves you with very little negotiating power — and very little equity by the time the company is worth something. Be disciplined early.
→ Stacking SAFEs without modeling conversion. Multiple SAFEs at different valuation caps create compounding dilution that founders don’t see until a priced round triggers everything at once. Model before you sign.
→ Ignoring the option pool mechanics. Letting investors force a large post-money option pool expansion is one of the most common ways founders lose more equity than they intended.
→ Raising before you have traction. In 2026, the bar at every stage is higher than it was in 2021. Investors who might have led a round on a deck alone now require real metrics. Build first. Raise when the numbers do the work for you, but this does not apply to every product.
→ Optimizing for check size instead of fit. The name on the term sheet matters. A misaligned investor on your cap table complicates every subsequent round, every board decision, and every potential exit. Choose investors who understand your market and have helped companies like yours succeed.
→ Not knowing your fully diluted ownership. Always calculate ownership on a fully diluted basis—including all outstanding options, unexercised warrants, unconverted SAFEs, and convertible notes. If you don’t know this number, you are making decisions blindly.
→ Neglecting the cap table from day one. The easiest time to clean up your cap table is before it gets complicated. Set it up properly at incorporation. Use proper equity management software — Carta is the industry standard, with a free tier for up to 25 stakeholders. Never let your cap table live in an informal spreadsheet once investors are involved.
JUST BEFORE YOU GO
Fundraising is not the goal. It is a tool.
The most powerful position you can be in when walking into an investor conversation is one where you do not desperately need the money because you have traction, revenue, and options. My ideological stance: The most powerful person at the table is the person who is comfortable leaving the table without a deal.
Know exactly what you are trading when you accept capital on any terms.
The founders who navigate fundraising well are not the ones who have the most connections or the best deck. They are the ones who understand the game and play it deliberately.
That starts with knowing what you are talking about before you walk into the room.
Written by CJ Benjamin
Startup Strategist and Lead Brand Strategist, Brandroom Inc.
Brandroom Inc. is a global brand strategy consulting and design firm working with founders, startups, and institutions across six countries. We help founders build brands worth funding. Click on ‘Start a project‘ to work with us.
Sources: Crunchbase 2025 funding data · PitchBook 2024–2025 medians · Carta founder ownership data · CRV Startup Equity Guide 2026 · DealRoom funding benchmarks · Spectup fundraising analysis (April 2026) · EQT ThinQ Cap Table Guide (2026) · Bloom Consulting · Terms.Law Cap Table Calculator · re:cap Cap Table Management Guide (2026)
